Page 237 - Presents News Today

- KVD900 Efficacious Within First Hours of Attack and Significantly Shortens Time to Improvement of Attack Symptoms - KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical

(0) Whole transcriptome analysis of ER+ breast cancers showed no substantial difference in gene expression between tumors from women younger than 50 and women older than 50 Whole transcriptome analysis confirms that genomic expression profiles from BluePrint ER+ Basal tumors and ER- Basal tumors are very similar, providing clinically actionable information to guide neoadjuvant treatment decisions FLEX real-world registry to enroll 10,000 patients with breast cancer by end of 2021, with ultimate...

DJ Harpoon presents updated interim clinical data for HPN424 at the 2021 ASCO Annual Meeting Arix Bioscience PLC (ARIX) Harpoon presents updated interim clinical data for HPN424 at the 2021 ASCO

- 61 patients with NRG1+ cancer have been enrolled, including 45 patients evaluable for response as of the April 13, 2021 data cutoff date- Encouraging early clinical activity observed, with confirmed

DJ Harpoon presents updated interim clinical data for HPN424 at the 2021 ASCO Annual Meeting Arix Bioscience PLC (ARIX) Harpoon presents updated interim clinical data for HPN424 at the 2021 ASCO

Data for investigational CD20xCD3 bispecific antibodies and new combination regimens with Polivy showed enhanced clinical benefits for people with non-Hodgkin lymphoma in early studies Basel, 4 June

ZYNLONTA LOTIS-2 updated data includes median duration of response of 13.4 months in heavily pre-treated patients with relapsed or refractory DLBCL Subgroup analyses include patients with double-

Next years Francis Bacon exhibition at the Royal Academy will prompt heightened interest in the artist once again, so make sure youre ahead of the game with this new book about him written by his close friend Yves Peyré. Francis Bacon or the Measure of Excess offers a touching tribute to the Irish painter, as well as providing insightful analysis into his work and creative process. Francis Bacon or the Measure of Excess, £35.07, Amazon Courtesy

Horizon Therapeutics plc Presents New Data on Robust Pipeline at EULAR European Congress of Rheumatology -- Early data from ongoing PROTECT trial suggest stable and durable response to KRYSTEXXA (pegloticase injection) therapy in treating uncontrolled gout among people with kidney transplants -- -- Data on the companys investigational compound (HZN-4920) under evaluation for rheumatoid arthritis will be presented during an oral session on June 3 at 10:15 a.m. CEST -- Horizon Therapeutics plc (N...

(0) Salt Lake City, Utah--(Newsfile Corp. - June 2, 2021) - Yesterday, President Kristy Hunt of Green Star Products, Inc. (OTC PINK: GSPI) announced the release of a new USA Today Special Publication on COVID-19, titled "America Forward" on 6/1/2021, that includes a full page on Viro Spectrum Shield. See attached USA Today Special Publication. USA Today "America Forward" publication was delivered to newsstands all over the US on June 1 st, 2021 and will be available for online viewing in 10-...